Group items tagged

MaRS tenant Axela Inc. pursues South American diagnostic assay market through MOU with Cria Opportunities Inc.

Crackdown looms on generic drug prices

Type A Events is proud to be part of the coordination team for the Nitric Oxide Symposium presented by MaRS Discovery District and NeurAxon taking place on May 27th and 28th, 2010.

The booming brain-fitness industry hopes to help with computer puzzles designed to sharpen your mental power. Baycrest and MaRS launched a company, Cogniciti, that aims to develop brain fitness products based on scientific principles introduced by the Rotman team.

Baycrest and MaRS launched a company, Cogniciti, that aims to develop brain fitness products based on scientific principles introduced by the Rotman team. Researchers are busy developing mental fitness products to sharpen cognition in the elderly.

U.S.-based market research firm states in the Vancouver Sun that "the brain fitness industry is projected to jump from $265 million in 2008 to between $1 billion and $5 billion by 2015." Cogniciti aims to develop brain fitness products based on scientific principles introduced by the Rotman team.

Cannasat Therapeutics (TSX-V), a specialty pharmaceutical company, has received the shareholder approval to change its corporate name to Cynapsus Therapeutics.

Gamemakers state "video games can be healthy food for the brain."Baycrest and MaRS launched a company, Cogniciti, that aims to develop brain fitness products based on scientific principles introduced by the Rotman team.

Calvin Still who helped founded MaRS Discovery District and was a Gairdner Award Winner recipient says "Canada lacks the venture capital needed to finance research for groundbreaking treatments." Dr. Min Zhuo, a U of T researcher is connecting the dots from sexual attraction to treatments for chronic pain.

There is opportunity to grow a significant neurotechnology industry in Ontario. MaRS Discovery District aims to help move promising discoveries out of the lab and into the marketplace.

Digital brain fitness products are being designed to sharpen memory. "Baycrest and MaRS launched a company, Cogniciti, that aims to develop brain fitness products based on scientific principles introduced by the Rotman team.

Cogniciti is a for profit company in the business of creating and marketing products designed to help adults extend their cognitive abilities longer in the lifespan. Cogiciti was launched by Baycrest and MaRS.

Profound Medical Inc, a MaRS client hopes to improve quality of life for men with prostate cancer by developing a faster, more precise treatment aimed at reducing side effects. Profound Medical won the $200,000 Premier's Catalyst Award for a start-up company with the best innovation. Avenir Medical Inc, a MaRS Client was named Ontario's Next Top Entrepreneur at the conference of the Ontario Centres of Excellence.

Harper committed the cancer funding, starting April 1 2012, while visiting Toronto's MaRS Discovery District. The funding announced today will help doctors detect cancer sooner and give health care workers, support groups and survivors the help they need to fight back against cancer. The funding builds on the program's progress on prevention, diagnosis, treatment and hope, on a path to a cure.

The week of October 3, 2011,  Segasist Technologies, a MaRS client and tenant will launch its' new cancer diagnostic tool Reconcillio at the American Society for Radiation Oncology conference. Reconcillio is Segasist Technologies' third product and is awaiting FDA approvals.

"The United States spends more on health care-related research and development than any other country. In 2003, it was estimated that the Federal government alone spent over $26 billion. Pharmaceutical companies, device manufacturers and other private companies invested over $10 billion more. At its best, the American health care system is capable of delivering care unsurpassed anywhere else in the world. Yet, a 1999 Institute of Medicine study estimated that as many as 98,000 Americans die each year from hospital related medical errors. A recent study by the Rand Corporation (a non-profit think tank) concluded that less than 50 percent of encounters with doctors and hospitals resulted in optimal, evidence-based treatment. Studies show that as many as 42 million Americans - almost 15 percent of the population - lack health care insurance. Surveys reveal that patients do not feel they have adequate information about their conditions, and that their experience with health care ranks below that of most other sectors, in fact below that of the post office. In the aggregate, the country is spending nearly $2 trillion on health care, and yet the nation's health care system does not meet acceptable thresholds for safety, quality, access or cost. In 2005, VHA Health Foundation's board of directors sought to better understand the reasons behind this paradox. The foundation commissioned Larry Keeley and his associates at Doblin Inc. to apply the rigorous analytical methods that are used in their evaluation of other American industries and companies. The project set out to discover when, where and how innovation was taking place in health care. It also sought to identify organizations that were developing model innovation processes, and to explore where opportunities for successful innovation might lay."